Implant-related infections demand advanced biomaterials capable of delivering localized, sustained antimicrobial activity while supporting tissue repair. Here, we present an engineered thermoresponsive hydrogel based on poly(N-vinylcaprolactam) (PNVCL), designed as a dual-function platform that enables temperature-triggered gelation, controlled tetracycline release, and osteogenic support. The PNVCL network was tailored to provide rapid sol–gel transition at physiological temperature, strong adhesion to moist surfaces, injectability into narrow implant geometries, high swelling capacity, slow degradation, and a stable drug-release profile—properties rarely combined within a single hydrogel system. To evaluate material performance, we employed a tiered biological framework comprising cytocompatibility assays, controlled physicochemical analyses, and antimicrobial testing against complex, polymicrobial biofilms, complemented by human in situ and in vivo multispecies infection models. The PNVCL–tetracycline hydrogel demonstrated potent antibacterial activity, preserved human gingival fibroblast viability, and sustained its structural integrity and release characteristics even under infection-associated inflammatory conditions. In vivo , the material simultaneously reduced bacterial burden, modulated pathogenic community structure, and promoted new bone formation with a higher degree of maturation, confirming its dual antimicrobial and osteogenic behavior. By integrating precisely engineered thermoresponsive behavior, controlled drug delivery, robust mechanical and interfacial properties, and validated biological functionality, this PNVCL–tetracycline hydrogel represents a material-driven, clinically relevant solution for treating implant-related infections. • Implant infections are common conditions that can lead to treatment failure. • Biomedical engineering has focused on sustained drug-releasing strategies. • A tetracycline-loaded hydrogel was developed for peri-implant infection control. • The hydrogel showed controlled release, antimicrobial activity, and cytocompatibility. • It reduced polymicrobial biofilms, altered their composition, and improved bone repair.
Dini et al. (Wed,) studied this question.